Budesonide formotrol Rotacap

Product Description

Budeflo 200 rotacap is a combination medication designed to manage and treat chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Each rotacap contains Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, two active ingredients that work synergistically to provide both immediate and long-term relief from symptoms.

Budesonide is a potent corticosteroid that reduces inflammation in the airways, helping to prevent asthma attacks and manage chronic symptoms. It works by inhibiting multiple types of inflammatory cells and mediators, thereby decreasing airway hyperresponsiveness and mucus production. This action helps in maintaining open airways, reducing the frequency and severity of asthma attacks.

Formoterol Fumarate Dihydrate, on the other hand, is a long-acting beta-agonist (LABA). It works by relaxing the muscles around the airways in the lungs, making it easier to breathe. Formoterol provides quick relief from bronchospasm and helps in maintaining open airways for up to 12 hours, making it effective for both day and night-time symptom control.

Together, Budesonide and Formoterol in Budeflo 200 rotacap provide a comprehensive approach to managing asthma and COPD, addressing both inflammation and bronchoconstriction. This combination therapy ensures that patients experience fewer symptoms, improved lung function, and a better quality of life. Regular use as prescribed by a healthcare professional can significantly reduce the frequency of asthma attacks and the need for rescue medication.